Isorhamnetin protects rat ventricular myocytes from ischemia and reperfusion injury

Experimental and Toxicologic Pathology

Volumn 63, Issue 1-2, 2011, Pages 33-38

  Zhang, Najuan ^a   Pei, Fei ^a   Wei, Huaying ^b   Zhang, Tongtong ^a   Yang, Chao ^a   Ma, Gang ^a   Yang, Chunlei ^a  

^a SICHUAN UNIVERSITY   (China)

^b Saier Biological Technology Co Ltd   (China)

Author keywords

Apoptosis; Ischemia and reperfusion injury; Isorhamnetin; Ventricular myocytes

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ISORHAMNETIN; LACTATE DEHYDROGENASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; TRANSCRIPTION FACTOR RELA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG STRUCTURE; ENZYME INHIBITION; FLOW CYTOMETRY; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE; IN VITRO STUDY; MUSCLE CELL; NEWBORN; NONHUMAN; RANDOMIZATION; RAT; REPERFUSION INJURY; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CELLS, CULTURED; FLAVONOLS; FLOW CYTOMETRY; GENE EXPRESSION; HEART VENTRICLES; L-LACTATE DEHYDROGENASE; MICROSCOPY, ELECTRON, TRANSMISSION; MOLECULAR STRUCTURE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; TRANSCRIPTION FACTOR RELA; TUMOR SUPPRESSOR PROTEIN P53;

RATTUS;

EID: 78650173838     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.09.005     Document Type: Article

References (41)

1. Bao M., Lou Y. Isorhamnetin prevent endothelial cell injuries from oxidized LDL via activation of p38 MAPK. Eur J Pharmacol 2006, 547:22-30.
2. Bravo L. Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 1998, 56:317-333.
3. Buja L.M. Modulation of the myocardial response to ischemia. Lab Invest 1997, 78:1345-1373.
4. Buja L.M., Entman M.L. Modes of myocardial cell injury and cell death in ischemic heart disease. Circulation 1998, 98:1355-1357.
5. Chambless L., Keil U., Dobson A., et al. Population versus clinical view of case fatality from acute coronary heart disease: results from the WHO MONICA Project 1985-1990. Circulation 1997, 96:3849-3859.
6. Chao D.T., Korsmeyer S.J. Bcl-2 family: regulators of cell death. Ann Immuno 1998, 16:395-419.
7. Fliss H., Gattinger D. Apoptosis in ischemic and reperfused rat myocardium. Circ Res 1996, 79:949-956.
8. Gross G.J., Auchampach J.A. Reperfusion injury: does it exist?. Mol Cell Cardiol 2007, 42:12-18.
9. Craig R.W. The BCL-2 gene family. Cancer Biol 1995, 6:35-43.
10. Gupta S., Purcell N.H., Lin A., et al. Activation of nuclear factor-kappaB is necessary for myotrophin-induced cardiac hypertrophy. Cell Biol 2002, 159:1019-1028.
11. Harlow E., Lane D. Using antibodies. A Laboratory Manual 1999, 161-184.
12. Hatoko M., Tanaka A., Kuwahara M., et al. Difference of molecular response to ischemia-reperfusion of rat skeletal muscle as a function of ischemic time: study of the expression of p53, p21 (WAF-1), Bax protein, and apoptosis. Ann Plast Surg 2002, 48:68-74.
13. Hyun S.K., Jung Y.J., Chung H.Y., et al. Isorhamnetin glycosides with free radical and ONOO-scavenging activities from the stamens of Nelumbo nucifera. Arch Pharm Res 2006, 29:287-292.
14. Hung L.M., Chen J.K., Lee R.S., et al. Beneficial effects of astringinin, a resveratrol analogue, on the ischemia and reperfusion damage in rat heart. Free Radic Biol Med 2001, 30:877-883.
15. Jonathan L., Remi Neviereb Beneficial effects of different flavonoids on functional recovery after ischemia and reperfusion in isolated rat heart. Bioorgan. Med. Chem. Lett. 2001, 11:23-27.
16. Juan D., PÉrez-Vizcaĺno F., JimÉnez J., et al. Flavonoids and cardiovascular diseases. Stud Nat Product Chem 2001, 25:565-605.
17. Kerr J.F., Wyllie A.H., Currie A.R. A basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257.
18. Kelly K.J., Plotkin Z., Vulgamott S.L., et al. P53 mediates the apoptotic response to GTP depletion after renal ischemia-reperfusion: protective role of a p53 inhibitor. J Am Soc Nephrol 2003, 14:128-138.
19. Lan K., HE J.L., Tian Y., et al. Intra-herb pharmacokinetics interaction between quercetin and isorhamentin. Acta Pharmacol Sin 2008, 29(11):1376-1382.
20. Leker R.R., Aharonowiz M., Greig N.H., et al. The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha. Exp Neurol 2004, 187:478-486.
21. Liu P., Xu B., Cavalieri T.A., et al. Pifithrin-alpha attenuates p53-mediated apoptosis and improves cardiac function in response to myocardial ischemia/reperfusion in aged rats. Shock 2006, 26:608-614.
22. Moll U.M., Wolff S., Speidel D., et al. Transcription-independent pro-apoptotic functions of p53. Curr Opin Cell Biol 2005, 17:631-636.
23. Nadal-Ginard B., Kajstura J., Leri A., et al. Myocyte death, growth and regeneration in cardiac hypertrophy and failure. Circ Res 2003, 92:139-150.
24. Palmen M., Daemen M.J., De Windt L.J., et al. Fibroblast growth factor-1 improves cardiac functional recovery and enhances cell survival after ischemia and reperfusion: a fibroblast growth factor receptor, protein kinase C, and tyrosine kinase-dependent mechanism. J. Am coll cardiol 2004, 44(5):1113-1123.
25. Perkins N.D. Integrating cell-signalling pathways with NF-κB and IKK function. Nat Rev Mol Cell Biol 2007, 8:49-62.
26. Piot C.A. Ischemic preconditioning decrease apoptosis in rat heart in vivo. Circulation 1997, 96:1598-1604.
27. Pozarowski P., Grabarek J., Darzynkiewicz Z. Current protocols in cell biology 2003, 18. John Wiley & Sons, 8-6.
28. Reed J.C. Mechanisms of apoptosis. Am J Pathol 2000, 157:1415-1430.
29. Saraste A. Apoptosis in human acute myocardial infarction. Circulation 1997, 95:320-323.
30. Sato M., Bagchi D., Tosaki A., et al. Grape seed proanthocyanidin reduces cardiomyocyte apoptosis by inhibiting ischemia/reperfusioninduced activation of JNK-1 and C-JUN. Free Radic Biol Med 2001, 31(6):729-737.
31. Sato S., Kajiyama Y., Sugano M., et al. Flavopiridol as a radio-sensitizer for esophageal cancer cell lines. Dis Esophagus 2004, 17:338-344.
32. Sidransky D., Hollstein M. Clinical implications of the p53 gene. Ann Med 1996, 47:285-301.
33. Suomela J.P., Ahotupa M., Yang B., et al. Absorption of flavonols derived from sea buckthorn (Hippophae rhamnoides L.) and their effect on emerging risk factors for cardiovascular disease in humans. J Agric Food Chem 2006, 54:7364-7369.
34. Sun M., Han J., Duan J., et al. Novel antitumor activities of Kushen flavonoids in vitro and in vivo. Phytother Res 2006, 21:269-277.
35. Spector D.L., Goldman R., Leinwand L.A., Cell A. Laboratory manual 1998, vol. 3. Cold Spring Harbor Laboratory Press, p. 1165-72.
36. Teng B.S., Lu Y.H., Wang Z.T., et al. In vitro anti-tumor activity of isorhamnetin isolated from Hippophae rhamnoides L. against BEL-7402 cells. Pharmacol Res 2006, 54:186-194.
37. Wang Z.R., Wang L., Ying, et al. Effect of total flavonoids of hippophae rhamnoides on contractile mechanics and calcium transfer in stretched myocyte. Space Med Med Eng 2000, 13:6-9.
38. Yin R.X., Yang D.Z., Li J.Q. Effects of cardiotrophin-1 on hemodynamics and cardiomyocyte apoptosis in rats with acute myocardial infarction. J Med Invest 2004, 51:29-37.
39. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat Rev Mol Cell Biol 2008, 9:47-59.
40. Zhao Z.Q., Velez D.A., Wang N.P., et al. Progressively developed myocardial apoptotic cell death during late phase of reperfusion. Apoptosis 2001, 6:279-290.
41. Zhao Z.Q., Nakamura M., Wang N.P., et al. Reperfusion induces myocardial apoptotic cell death. Cardiovasc Res 2000, 45:651-660.